NG Bio

NG Bio, an early-stage investor and venture builder addressing the harmful immune responses, such as inflammation, that cause or exacerbate many of the major human diseases. By tackling these, we extend human health span and longevity. As scientists continue to unlock the secrets to the drivers of inflammation, NG Bio is creating the next generation of medicines and diagnostics in the breakthrough areas of cure, personalisation, regeneration, and women’s health. We partner with world leading entrepreneurs, research institutions and academic institutions across the globe to realise our vision of life with control over chronic diseases.